Cargando…
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial
SIMPLE SUMMARY: Active therapeutic options in advanced soft tissue sarcoma (STS), able to induce durable objective responses, are limited beyond first-line chemotherapy. Although results obtained in clinical trials suggest there is a high probability for patients with STS to benefit from treatment w...
Autores principales: | Grünwald, Viktor, Pink, Daniel, Egerer, Gerlinde, Schalk, Enrico, Augustin, Marinela, Deinzer, Christoph K. W., Kob, Viola, Reichert, Dietmar, Kebenko, Maxim, Brandl, Stephan, Hahn, Dennis, Lindner, Lars H., Hoiczyk, Mathias, Ringsdorf, Uta, Hanker, Lars C., Hempel, Dirk, De Rivas, Beatriz, Wismann, Tobias, Ivanyi, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653615/ https://www.ncbi.nlm.nih.gov/pubmed/36358652 http://dx.doi.org/10.3390/cancers14215234 |
Ejemplares similares
-
Trabectedin plus pegylated liposomal doxorubicin (PLD) for patients with platinum-sensitive recurrent ovarian cancer: a prospective, observational, multicenter study
por: Runnebaum, Ingo B., et al.
Publicado: (2018) -
Trabectedin in metastatic soft tissue sarcomas: Role of pretreatment and age
por: HOICZYK, MATHIAS, et al.
Publicado: (2013) -
Trabectedin for Metastatic Soft Tissue Sarcoma: A Retrospective Single Center Analysis
por: Schmitt, Thomas, et al.
Publicado: (2010) -
The Use of Positron Emission Tomography in Soft Tissue Sarcoma Patients under Therapy with Trabectedin
por: Kasper, Bernd, et al.
Publicado: (2009) -
Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient(®) in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)
por: Pink, Daniel, et al.
Publicado: (2021)